de Weger RA - Search Results

1

Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures.

Lokhorst HM, Lamme T, de Smet M, Klein S, de Weger RA, van Oers R, Bloem AC. Lokhorst HM, et al. Among authors: de smet m, de weger ra. Blood. 1994 Oct 1;84(7):2269-77. Blood. 1994. PMID: 7919345 Free article.

2

Expression of two interleukin 4 mRNA isoforms in B lymphoid cells.

Klein SC, Golverdingen JG, van Wichen DF, Bouwens AG, Stuij I, Tilanus MG, Bast EJ, de Weger RA. Klein SC, et al. Among authors: de weger ra. Cell Immunol. 1996 Feb 1;167(2):259-68. doi: 10.1006/cimm.1996.0034. Cell Immunol. 1996. PMID: 8603435

3

Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.

Verdonck LF, Petersen EJ, Lokhorst HM, Nieuwenhuis HK, Dekker AW, Tilanus MG, de Weger RA. Verdonck LF, et al. Among authors: de weger ra. Bone Marrow Transplant. 1998 Dec;22(11):1057-63. doi: 10.1038/sj.bmt.1701496. Bone Marrow Transplant. 1998. PMID: 9877267

4

Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses.

de Haart SJ, Willems SM, Mutis T, Koudijs MJ, van Blokland MT, Lokhorst HM, de Weger RA, Minnema MC. de Haart SJ, et al. Among authors: de weger ra. Blood Cancer J. 2016 May 20;6(5):e426. doi: 10.1038/bcj.2016.35. Blood Cancer J. 2016. PMID: 27206246 Free PMC article. No abstract available.

5

An improved, sensitive, non-radioactive in situ hybridization method for the detection of cytokine mRNAs.

Klein SC, van Wichen DF, Golverdingen JG, Jacobse KC, Broekhuizen R, de Weger RA. Klein SC, et al. Among authors: de weger ra. APMIS. 1995 May;103(5):345-53. APMIS. 1995. PMID: 7654359

6

An alternatively spliced interleukin 4 form in lymphoid cells.

Klein SC, Golverdingen JG, Bouwens AG, Tilanus MG, de Weger RA. Klein SC, et al. Among authors: de weger ra. Immunogenetics. 1995;41(1):57. doi: 10.1007/BF00188440. Immunogenetics. 1995. PMID: 7806280 No abstract available.

7

Release of cytokines and soluble cell surface molecules by PBMC after activation with the bispecific antibody CD3 x CD19.

Klein SC, Boer LH, de Weger RA, de Gast GC, Bast EJ. Klein SC, et al. Among authors: de gast gc, de weger ra. Scand J Immunol. 1997 Nov;46(5):452-8. doi: 10.1046/j.1365-3083.1997.d01-151.x. Scand J Immunol. 1997. PMID: 9393627 Free article.

8

Clinical experience with CD3 x CD19 bispecific antibodies in patients with B cell malignancies.

De Gast GC, Van Houten AA, Haagen IA, Klein S, De Weger RA, Van Dijk A, Phillips J, Clark M, Bast BJ. De Gast GC, et al. Among authors: de weger ra. J Hematother. 1995 Oct;4(5):433-7. doi: 10.1089/scd.1.1995.4.433. J Hematother. 1995. PMID: 8581381 Clinical Trial.

9

Lymphoblastic lymphoma with a triple-hit profile: a rare but distinct and relevant entity.

Hiemcke-Jiwa LS, Leguit RJ, van der Veken LT, Buijs A, Leeuwis JW, de Boer M, Jiwa NM, Bloem AC, Petersen EJ, de Weger RA, Huibers MMH. Hiemcke-Jiwa LS, et al. Among authors: de boer m, de weger ra. Hum Pathol. 2017 May;63:171-176. doi: 10.1016/j.humpath.2016.11.002. Epub 2016 Nov 17. Hum Pathol. 2017. PMID: 27867103

10

CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia.

van Montfrans JM, Hoepelman AI, Otto S, van Gijn M, van de Corput L, de Weger RA, Monaco-Shawver L, Banerjee PP, Sanders EA, Jol-van der Zijde CM, Betts MR, Orange JS, Bloem AC, Tesselaar K. van Montfrans JM, et al. Among authors: de weger ra. J Allergy Clin Immunol. 2012 Mar;129(3):787-793.e6. doi: 10.1016/j.jaci.2011.11.013. Epub 2011 Dec 24. J Allergy Clin Immunol. 2012. PMID: 22197273 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page